These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2472704)
1. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Roehrig JT; Hunt AR; Johnson AJ; Hawkes RA Virology; 1989 Jul; 171(1):49-60. PubMed ID: 2472704 [TBL] [Abstract][Full Text] [Related]
2. Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. Hawkes RA; Roehrig JT; Hunt AR; Moore GA J Gen Virol; 1988 May; 69 ( Pt 5)():1105-9. PubMed ID: 2453607 [TBL] [Abstract][Full Text] [Related]
3. T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. Mathews JH; Allan JE; Roehrig JT; Brubaker JR; Uren MF; Hunt AR J Virol; 1991 Oct; 65(10):5141-8. PubMed ID: 1832722 [TBL] [Abstract][Full Text] [Related]
5. Type-specific monoclonal antibodies produced to proteins of Murray Valley encephalitis virus. Hall RA; Burgess GW; Kay BH Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():51-6. PubMed ID: 2453454 [TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes. Mathews JH; Roehrig JT; Brubaker JR; Hunt AR; Allan JE J Virol; 1992 Nov; 66(11):6555-62. PubMed ID: 1383567 [TBL] [Abstract][Full Text] [Related]
7. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. Kimura-Kuroda J; Yasui K J Gen Virol; 1986 Dec; 67 ( Pt 12)():2663-72. PubMed ID: 2432163 [TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Hunt AR; Johnson AJ; Roehrig JT Virology; 1990 Dec; 179(2):701-11. PubMed ID: 2146802 [TBL] [Abstract][Full Text] [Related]
9. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus. Hall RA; Kay BH; Burgess GW; Clancy P; Fanning ID J Gen Virol; 1990 Dec; 71 ( Pt 12)():2923-30. PubMed ID: 1703213 [TBL] [Abstract][Full Text] [Related]
10. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. Mandl CW; Guirakhoo F; Holzmann H; Heinz FX; Kunz C J Virol; 1989 Feb; 63(2):564-71. PubMed ID: 2463377 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. Roehrig JT; Johnson AJ; Hunt AR; Beaty BJ; Mathews JH J Virol; 1992 Jun; 66(6):3385-90. PubMed ID: 1374807 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT; Bolin RA; Kelly RG Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950 [TBL] [Abstract][Full Text] [Related]
14. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus. Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115 [TBL] [Abstract][Full Text] [Related]
15. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006 [TBL] [Abstract][Full Text] [Related]
16. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Megret F; Hugnot JP; Falconar A; Gentry MK; Morens DM; Murray JM; Schlesinger JJ; Wright PJ; Young P; Van Regenmortel MH Virology; 1992 Apr; 187(2):480-91. PubMed ID: 1372140 [TBL] [Abstract][Full Text] [Related]
17. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition. Heinz FX; Berger R; Tuma W; Kunz C Virology; 1983 Oct; 130(2):485-501. PubMed ID: 6196909 [TBL] [Abstract][Full Text] [Related]
18. Mapping of linear antigenic sites on the S glycoprotein of a neurotropic murine coronavirus with synthetic peptides: a combination of nine prediction algorithms fails to identify relevant epitopes and peptide immunogenicity is drastically influenced by the nature of the protein carrier. Daniel C; Lacroix M; Talbot PJ Virology; 1994 Aug; 202(2):540-9. PubMed ID: 8030220 [TBL] [Abstract][Full Text] [Related]
19. Analysis of computer-predicted antibody inducing epitope on Japanese encephalitis virus. Kutubuddin M; Gore MM; Banerjee K; Ghosh SN; Kolaskar AS Acta Virol; 1993 Dec; 37(6):417-28. PubMed ID: 7516621 [TBL] [Abstract][Full Text] [Related]
20. Production of virus-specific antisera using synthetic peptides corresponding to sequences in the yellow fever E protein: brief report. Jackson RE; Phillpotts RJ Viral Immunol; 1997; 10(1):11-4. PubMed ID: 9095527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]